Clinical Variability in Cardiovascular Disease Risk Factor Screening and Management in Adolescent and Young Adult Women with Polycystic Ovary Syndrome

• Published in: Journal of pediatric & adolescent gynecology Vol. 28; no. 5; pp. 317 - 323
• Main Authors: Baer, Tamara E., Milliren, Carly E., Walls, Courtney, DiVasta, Amy D.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.10.2015
• Subjects: Adolescent; Adolescents; Adult; Body Mass Index; Body Weight; Cardiovascular Diseases - diagnosis; Cardiovascular Diseases - etiology; Cardiovascular risk factors; Child; Diabetes Mellitus, Type 2 - complications; Female; Follow-Up Studies; Humans; Hyperinsulinism; Insulin Resistance; Mass Screening - methods; Obesity; Obesity - complications; Obstetrics and Gynecology; Overweight - complications; PCOS; Pediatrics; Polycystic Ovary Syndrome - complications; Retrospective Studies; Risk Factors; Young Adult; Obesity; Insulin resistance; PCOS; Adolescents; Cardiovascular risk factors
• ISSN: 1083-3188; 1873-4332; 1873-4332
• DOI: 10.1016/j.jpag.2014.09.010

To review the clinical presentation, evaluation, and management of normal-weight (NW), overweight (OW), and obese (OB) adolescent and young adult women with polycystic ovary syndrome (PCOS) during a 2-year follow-up. Retrospective chart review. One hundred seventy-three adolescent and young adult women, aged 12-22 years, diagnosed with PCOS. Demographic, health data, and laboratory measures were abstracted from 3 clinic visits: baseline and 1- and 2-year follow-up. Subjects were classified as NW, OW, or OB. Longitudinal data were analyzed using repeated-measures analysis of variance. Body mass index, self-reported concerns, and lifestyle changes. Most patients (73%) were OW or OB. Family history of type 2 diabetes was greater in OW (38%) and OB (53%) patients compared with NW (22%) patients (P = .002). Acanthosis nigricans was identified in OW (62%) and OB (21%) patients but not in NW patients (0%; P < .001). OW and OB patients had higher fasting insulin (P < .001) and lower high-density lipoprotein cholesterol (P = .005) levels than NW patients, although screening rates were low. Body mass index Z-scores decreased in both OW and OB patients over time (0.07 unit/yr, P < .001). Most patients with PCOS were OW or OB. Substantial clinical variability existed in cardiovascular disease (CVD) screening; among those screened, OW and OB patients had greater CVD risk factors. Despite self-reported concerns about weight and diabetes risk among OW and OB patients, no clinically significant change in body mass index percentile occurred. Evidence-based interventions and recommendations for screening tests are needed to address CVD risk in adolescents and young adults with PCOS.